BNO 0.00% 1.0¢ bionomics limited

Net Asset Backing is MINUS 0.3c

  1. 4,664 Posts.
    lightbulb Created with Sketch. 1062
    The December 2019 half year financials are out.
    They show continued massive losses.
    They show that the Net Tangible Asset Backing is MINUS 0.3c per share.
    They announced positive pharmacokinetic results for BNC 210 (again).
    The FDA has granted "Fast Track" designation for BNC 210 development for PTSD.
    The cash position at 31 December was $9.388m
    Borrowings are $12.599m
    Net Cash position is therefore MINUS $3.211m
    Goodwill is in the books at $12.774m - a ridiculous assertion - what is the basis of the valuation I wonder?????
    Other intangible assets are in the books at $12.213m - whatever they are? Presumable capitalised R&D with little chance of being realised I suspect???
    If Goodwill and Intangibles are included at zero, then the company's balance sheet would look a whole lot worse.
    Who are the Auditors and would you trust them????
    Captain Snooze only has to keep slurping out those fees until June 30 2020 - and then he will disappear before it all blows up.......
    What are the odds????
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.